4
Changes in Ownership
Fulcrum Therapeutics, Inc. Filed Acc 0001104659-19-041304
Director bought 81,250 shares at $16.00 ($1,300,000)
- Director acquired 5,595,238 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| LEVIN MARK J Director | 2019-07-22 | Conversion | +5,595,238 | 5,880,952 | I: show line 1 in the form | ||
| LEVIN MARK J Director | 2019-07-22 | Purchase | +81,250 | $16.00 | $1,300,000 | 5,962,202 | I: show line 2 in the form |
| Open-market purchases · 81,250 sh · avg $16.00 · $1,300,000 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| LEVIN MARK J Director | 2019-07-22 | Conversion · Series A Preferred Stock | −39,166,667 | 0 | I: show line 3 in the form |
Loading xslF345X03/a4.xml…